Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study (Q73328285)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

1

A M Tonkin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

11

H D White

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

D Colquhoun

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Emberson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

W Hague

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

A Keech

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Lane

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S MacMahon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

J Shaw

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R J Simes

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

P L Thompson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

D Hunt

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

9245

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

1871-1875

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

Molecular bases of the acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

Design features and baseline characteristics of the LIPID (long-term intervention with pravastatin in ischemic disease) study: A randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

Evidence for the benefit of early intervention with pravastatin for secondary prevention of cardiovascular events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

Changes in serum lipid concentrations during first 24 hours after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903257-8

7 January 2021

10.1016/S0140-6736(00)03257-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11130382%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference